Staff
James R. Berenson, MD

President and CEO - James R. Berenson, MD, Inc.
Medical & Scientific Director - Institute for Myeloma
& Bone Cancer Research (IMBCR)
Chief Executive Officer - Oncotherapeutics
- Love Is All You Need – Movie Premiere Benefiting the Institute for Myeloma & Bone Cancer Research March 28, 2013
- Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma February 19, 2013
- CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma November 19, 2012
- Myeloma Cure Panel Broadcast – Dr. James Berenson will discuss Multiple Myeloma disease control Without Transplant November 9, 2012
- Updates in the Treatment of Multiple Myeloma October 26, 2012
- Kyphon® Balloon Kyphoplasty Found Beneficial for Treating Spinal Fractures in Cancer Patients February 16, 2011
- Phase I/II trial assessing bendamustine plus bortezomib combination therapy for the treatment of patients with relapsed or refractory multiple myeloma February 19, 2013
- CEP-18770 (delanzomib) in combination with dexamethasone and lenalidomide inhibits the growth of multiple myeloma November 19, 2012
- Myeloma Cure Panel Broadcast – Dr. James Berenson will discuss Multiple Myeloma disease control Without Transplant November 9, 2012
- Updates in the Treatment of Multiple Myeloma October 26, 2012






